J. Vergeront

发表

Cryptosporidiosis-associated mortality following a massive waterborne outbreak in Milwaukee, Wisconsin.

N. Hoxie, K. Blair, J. Davis, 1997, American journal of public health.

Wisconsin trends in pneumonia and influenza mortality, 1980-2003.

N. Hoxie, J. Vergeront, C. Schumann, 2006, WMJ : official publication of the State Medical Society of Wisconsin.

Molecular epidemiology of antibiotic resistance in salmonella from animals and human beings in the United States.

J. P. Reardon, A. Medeiros, T. O'Brien, 1982, The New England journal of medicine.

Human immunodeficiency virus seroprevalence and drug-using behavior in Milwaukee intravenous drug abusers.

E. Belongia, J. Davis, J. Vergeront, 1988, Journal of acquired immune deficiency syndromes.

Border hopping as a consequence of premarital HIV screening: the Kenosha diamond.

E. Belongia, J. Davis, J. Vergeront, 1988, JAMA.

The disease spectrum, epidemiology, and etiology of toxic-shock syndrome.

J. Davis, J. Vergeront, M. Bergdoll, 1984, Annual review of microbiology.

Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin.

N. Hoxie, J. Vergeront, M. Hurie, 2006, WMJ : official publication of the State Medical Society of Wisconsin.

Rapid Hepatitis C Testing Among Persons at Increased Risk for Infection — Wisconsin, 2012–2013

J. P. Davis, J. Vergeront, L. Stockman, 2014, MMWR. Morbidity and mortality weekly report.

Provider Workforce Assessment in a Rural Hepatitis C Epidemic

R. Westergaard, J. Vergeront, L. Stockman, 2015, Journal of primary care & community health.

Hepatitis C virus infection: an overview of Wisconsin's public health resources.

J. Vergeront, M. Hurie, W. Reiser, 2006, WMJ : official publication of the State Medical Society of Wisconsin.

Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014

R. Westergaard, J. Vergeront, L. Stockman, 2016, Public health reports.

Transmission Patterns in a Low HIV-Morbidity State — Wisconsin, 2014–2017

J. O. Wertheim, A. Oster, J. Vergeront, 2019, MMWR. Morbidity and mortality weekly report.

The effect of publicity on the reporting of toxic-shock syndrome in Wisconsin.

J. Davis, J. Vergeront, J. Davis, 1982, The Journal of infectious diseases.

Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection

R. Westergaard, J. Vergeront, Sheila M. Guilfoyle, 2019, Public health reports.

Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome.

J. Davis, J. Vergeront, M. Bergdoll, 1983, The Journal of infectious diseases.

Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin.

B. Varkey, L. Kaufman, J. Davis, 1986, The New England journal of medicine.

Toxic shock syndrome: relation to catamenial products, personal health and hygiene, and sexual practices.

M. Osterholm, R. Gibson, J. Davis, 1982, Annals of internal medicine.

Campylobacter infection associated with raw milk. An outbreak of gastroenteritis due to Campylobacter jejuni and thermotolerant Campylobacter fetus subsp fetus.

M. Blaser, J. Davis, D. J. Brenner, 1986, JAMA.

HIV infection in Wisconsin: state and national resources for clinicians and patients.

J. Davis, J. Vergeront, T. Dierwechter, 2000, WMJ : official publication of the State Medical Society of Wisconsin.

Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways.

J. P. Davis, L. Kaufman, J. Davis, 1987, The American review of respiratory disease.

Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis.

J. Davis, B. Klein, J. Vergeront, 1986, Seminars in respiratory infections.

Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin.

B. Varkey, L. Kaufman, B. Klein, 1987, The Journal of infectious diseases.

Development of long-term specific cellular immunity after acute Blastomyces dermatitidis infection: assessments following a large point-source outbreak in Wisconsin.

B. Klein, J. Vergeront, R. Bradsher, 1990, The Journal of infectious diseases.

Clinical and epidemiologic features of a massive waterborne outbreak of cryptosporidiosis in persons with HIV infection.

N. Hoxie, D. Addiss, J. Vergeront, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome.

J. Vergeront, M. Bergdoll, R. Reiser, 1982, Annals of internal medicine.

Tri-state toxic-shock syndrome study. II. Clinical and laboratory findings.

C. Helms, M. Osterholm, J. Vergeront, 1982, The Journal of infectious diseases.

Tri-State Toxic-Shock Syndrome Study. I. Epidemiologic Findings

J. P. Davis, C. Helms, J. Mandel, 1982 .

Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin.

J. Vergeront, M. Bergdoll, P. Chesney, 1985, The Journal of infectious diseases.

Possible host-defense mechanisms in toxic shock syndrome.

J. Vergeront, P. Chesney, J. Davis, 1982, Annals of internal medicine.

Increased Risk for Mother-to-Infant Transmission of Hepatitis C Virus Among Medicaid Recipients ― Wisconsin, 2011–2015

J. Vergeront, L. Stockman, Sheila M. Guilfoyle, 2017, MMWR. Morbidity and mortality weekly report.

HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin.

N. Hoxie, J. Pfister, J. Vergeront, 1990, American journal of public health.

HIV seroprevalence among male prison inmates in the Wisconsin Correctional System.

N. Hoxie, J. Pfister, B. Haase, 1998, WMJ : official publication of the State Medical Society of Wisconsin.

HIV seropositivity rates in outreach-based counseling and testing services: program evaluation.

David R. Holtgrave, S. Pinkerton, N. Hoxie, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Partner Referral by HIV-Infected Persons to Partner Counseling and Referral Services (PCRS) - Results from a Demonstration Project

Emeka Oraka, J. Vergeront, Binwei Song, 2012, The open AIDS journal.

Reductions in transmission risk behaviors in HIV-positive clients receiving prevention case management services: findings from a community demonstration project.

N. Hoxie, S. Catz, M. Brondino, 2005, AIDS education and prevention : official publication of the International Society for AIDS Education.

Toxic shock syndrome: management and long-term sequelae.

T. Warner, R. Chesney, J. Vergeront, 1982, Annals of internal medicine.

Setting standards for the Wisconsin HIV Counseling and Testing Program: an application of threshold analysis.

David R. Holtgrave, S. Pinkerton, N. Hoxie, 1997, Journal of public health management and practice : JPHMP.

Academic health departments as training sites for future public health leaders: a partnership model in Wisconsin.

P. Remington, J. Vergeront, T. Oliver, 2014, Journal of public health management and practice : JPHMP.

HIV seroprevalence among patients attending a Milwaukee clinic for sexually transmitted diseases: findings from four annual surveys, 1988-1991.

N. Hoxie, J. Pfister, J. Vergeront, 1993, Wisconsin medical journal.

Improving estimates of HIV-1 seroprevalence among childbearing women: use of smaller blood spots.

N. Hoxie, J. Pfister, J. Vergeront, 1992, American journal of public health.

HIV-1 among childbearing women and newborns in Wisconsin.

N. Hoxie, J. Pfister, J. Vergeront, 1990, Wisconsin medical journal.

Estimates of Prenatal HIV, Hepatitis B Virus, and Hepatitis C Virus Testing Among Pregnant People Enrolled in Wisconsin Medicaid, 2011–2015

J. Vergeront, L. Stockman, Sheila M. Guilfoyle, 2019, Maternal and Child Health Journal.

Toxic shock syndrome: a critique of the 1980 Wisconsin case-control study.

J. Vergeront, P. Chesney, P. Wand, 1982, Annals of internal medicine.

Prenatal HIV testing in Wisconsin: results of a survey among women who gave birth in 2003.

N. Hoxie, J. Vergeront, W. Reiser, 2006, WMJ : official publication of the State Medical Society of Wisconsin.

Meeting the challenge of early identification of HIV infection in primary care.

J. Vergeront, W. Reiser, J. Druckenmiller, 1998, Wisconsin Medical Journal.

“Don’t Deny Yourself a Seat at the Table”: Supporting the Leadership Development of MSM of Color in HIV Services

J. Vergeront, Katherine G. Quinn, Hester Wolfe, 2020, Health promotion practice.

Developing a Patient Navigation Program to Improve Engagement in HIV Medical Care and Viral Suppression: A Demonstration Project Protocol

R. Westergaard, J. Vergeront, A. Meier, 2017, AIDS and Behavior.

Implementing a Standardized Social Networks Testing Strategy in a Low HIV Prevalence Jurisdiction

R. Westergaard, J. Vergeront, Michelle R. Broaddus, 2018, AIDS and Behavior.

Rapid Hepatitis C Testing Among Persons at Increased Risk for Infection — Wisconsin, 2012–2013

J. P. Davis, J. Vergeront, Sheila M. Guilfoyle, 2014, MMWR. Morbidity and mortality weekly report.

Provider Workforce Assessment in a Rural Hepatitis C Epidemic

R. Westergaard, J. Vergeront, J. Fangman, 2015, Journal of primary care & community health.

Premarital HIV Screening-Reply

J. P. Davis, E. Belongia, J. Vergeront, 1989 .

Incorporating Rapid HIV Testing into Partner Counseling and Referral Services

A. Oster, J. Vergeront, Binwei Song, 2008, Public health reports.

Recovery of staphylococcal enterotoxin F from the breast milk of a woman with toxic-shock syndrome.

J. Vergeront, M. Bergdoll, B. Crass, 1982, The Journal of infectious diseases.